| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.006 |